ADIL
Price
$0.34
Change
+$0.01 (+3.03%)
Updated
Sep 26 closing price
Capitalization
7.51M
VANI
Price
$1.43
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
84.72M
51 days until earnings call
Interact to see
Advertisement

ADIL vs VANI

Header iconADIL vs VANI Comparison
Open Charts ADIL vs VANIBanner chart's image
Adial Pharmaceuticals
Price$0.34
Change+$0.01 (+3.03%)
Volume$604.15K
Capitalization7.51M
Vivani Medical
Price$1.43
Change-$0.00 (-0.00%)
Volume$61.64K
Capitalization84.72M
ADIL vs VANI Comparison Chart in %
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. VANI commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a Buy and VANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ADIL: $0.34 vs. VANI: $1.43)
Brand notoriety: ADIL and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 39% vs. VANI: 40%
Market capitalization -- ADIL: $7.51M vs. VANI: $84.72M
ADIL [@Biotechnology] is valued at $7.51M. VANI’s [@Biotechnology] market capitalization is $84.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, ADIL is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 5 TA indicator(s) are bullish while VANI’s TA Score has 6 bullish TA indicator(s).

  • ADIL’s TA Score: 5 bullish, 3 bearish.
  • VANI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ADIL and VANI are a good buy in the short-term.

Price Growth

ADIL (@Biotechnology) experienced а -1.69% price change this week, while VANI (@Biotechnology) price change was +1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

VANI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($84.7M) has a higher market cap than ADIL($7.51M). VANI YTD gains are higher at: 23.276 vs. ADIL (-65.931). ADIL has higher annual earnings (EBITDA): -8.3M vs. VANI (-26.38M). VANI has more cash in the bank: 6.79M vs. ADIL (5.92M). ADIL has less debt than VANI: ADIL (194K) vs VANI (18.6M). ADIL (0) and VANI (0) have equivalent revenues.
ADILVANIADIL / VANI
Capitalization7.51M84.7M9%
EBITDA-8.3M-26.38M31%
Gain YTD-65.93123.276-283%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.92M6.79M87%
Total Debt194K18.6M1%
FUNDAMENTALS RATINGS
ADIL vs VANI: Fundamental Ratings
ADIL
VANI
OUTLOOK RATING
1..100
1097
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6543
P/E GROWTH RATING
1..100
49100
SEASONALITY SCORE
1..100
n/a29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADIL's Valuation (17) in the Pharmaceuticals Major industry is somewhat better than the same rating for VANI (70) in the null industry. This means that ADIL’s stock grew somewhat faster than VANI’s over the last 12 months.

ADIL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that ADIL’s stock grew similarly to VANI’s over the last 12 months.

ADIL's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that ADIL’s stock grew similarly to VANI’s over the last 12 months.

VANI's Price Growth Rating (43) in the null industry is in the same range as ADIL (65) in the Pharmaceuticals Major industry. This means that VANI’s stock grew similarly to ADIL’s over the last 12 months.

ADIL's P/E Growth Rating (49) in the Pharmaceuticals Major industry is somewhat better than the same rating for VANI (100) in the null industry. This means that ADIL’s stock grew somewhat faster than VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADILVANI
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALXO1.870.08
+4.47%
ALX Oncology Holdings
CPRX19.520.39
+2.04%
Catalyst Pharmaceuticals
MYNZ1.55N/A
N/A
Mainz Biomed N.V.
CBNK32.10-0.43
-1.32%
Capital Bancorp
XPO126.05-3.10
-2.40%
XPO

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with VANI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+2.81%
VANI - ADIL
37%
Loosely correlated
N/A
CLYM - ADIL
34%
Loosely correlated
+1.43%
GDTC - ADIL
30%
Poorly correlated
+1.02%
VYNE - ADIL
30%
Poorly correlated
+5.00%
VTVT - ADIL
28%
Poorly correlated
-2.10%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
N/A
VTVT - VANI
59%
Loosely correlated
-2.10%
ENVB - VANI
41%
Loosely correlated
-0.62%
NTLA - VANI
30%
Poorly correlated
-1.81%
KYTX - VANI
29%
Poorly correlated
-3.94%
GLABF - VANI
29%
Poorly correlated
N/A
More